Insulin-like growth factor I and prostate cancer.
O'Brien
M F
MF
Department of Surgery, University College Dublin, Mater Misericordiae Hospital, Dublin, Ireland.
Watson
R W
RW
Fitzpatrick
J M
JM
D000818:Animals; D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000032:analysis; D001859:Bone Neoplasms / Q000556:secondary; D002465:Cell Movement; D018450:Disease Progression; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism; D008297:Male; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000628:therapy; D017451:Receptors, Somatomedin / Q000378:metabolism; D015398:Signal Transduction; D013002:Somatomedins / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D014408:Biomarkers, Tumor; D018972:Insulin-Like Growth Factor Binding Protein 3; D017451:Receptors, Somatomedin; D013002:Somatomedins; D017430:Prostate-Specific Antigen